Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Director Sells $40,250.00 in Stock

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Director Riad Hussein El-Dada sold 175,000 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $0.23, for a total value of $40,250.00. Following the transaction, the director directly owned 175,000 shares in the company, valued at approximately $40,250. This represents a 50.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Greenland Mines Ltd. Common Stock Price Performance

Greenland Mines Ltd. Common Stock stock opened at $0.26 on Monday. The firm has a market capitalization of $35.35 million, a P/E ratio of -0.80 and a beta of 6.97. Greenland Mines Ltd. Common Stock has a 1-year low of $0.21 and a 1-year high of $1.65. The company’s 50-day moving average is $0.38 and its 200 day moving average is $0.39.

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) last released its earnings results on Wednesday, May 20th. The company reported ($0.15) earnings per share for the quarter.

Hedge Funds Weigh In On Greenland Mines Ltd. Common Stock

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in GRML. Jane Street Group LLC purchased a new position in Greenland Mines Ltd. Common Stock during the 2nd quarter worth approximately $26,000. XTX Topco Ltd increased its stake in shares of Greenland Mines Ltd. Common Stock by 101.2% in the fourth quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock worth $46,000 after acquiring an additional 80,768 shares during the period. Geode Capital Management LLC raised its holdings in shares of Greenland Mines Ltd. Common Stock by 51.8% during the fourth quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock worth $142,000 after purchasing an additional 167,905 shares during the last quarter. Renaissance Technologies LLC acquired a new position in Greenland Mines Ltd. Common Stock during the fourth quarter valued at $126,000. Finally, Brummer Multi Strategy AB acquired a new position in Greenland Mines Ltd. Common Stock during the fourth quarter valued at $175,000. Hedge funds and other institutional investors own 20.07% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Wall Street Zen upgraded shares of Greenland Mines Ltd. Common Stock to a “sell” rating in a report on Saturday, May 2nd. Weiss Ratings upgraded shares of Greenland Mines Ltd. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, June 9th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Greenland Mines Ltd. Common Stock Company Profile

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.